The Fort Worth Press - Who should get paid for nature's sequenced genes?

USD -
AED 3.673029
AFN 68.039825
ALL 93.57259
AMD 399.590344
ANG 1.80346
AOA 914.498139
ARS 1012.196988
AUD 1.545082
AWG 1.8
AZN 1.706225
BAM 1.85985
BBD 2.00485
BDT 119.580825
BGN 1.85841
BHD 0.376957
BIF 2956.475432
BMD 1
BND 1.345581
BOB 6.914226
BRL 6.073898
BSD 1.000666
BTN 84.725986
BWP 13.651708
BYN 3.272093
BYR 19600
BZD 2.006276
CAD 1.405525
CDF 2870.00047
CHF 0.885505
CLF 0.035375
CLP 976.101734
CNY 7.285203
CNH 7.30458
COP 4452.26
CRC 507.702548
CUC 1
CUP 26.5
CVE 104.858496
CZK 23.975039
DJF 178.187316
DKK 7.09877
DOP 60.574939
DZD 133.792638
EGP 49.748498
ERN 15
ETB 124.980221
EUR 0.951825
FJD 2.270204
FKP 0.789317
GBP 0.790298
GEL 2.845033
GGP 0.789317
GHS 15.159757
GIP 0.789317
GMD 71.000037
GNF 8625.034472
GTQ 7.726395
GYD 209.254557
HKD 7.783445
HNL 25.338063
HRK 7.133259
HTG 131.182305
HUF 394.536982
IDR 15958.45
ILS 3.62197
IMP 0.789317
INR 84.722503
IQD 1310.872108
IRR 42100.000039
ISK 138.660243
JEP 0.789317
JMD 156.899478
JOD 0.709097
JPY 149.101015
KES 129.495895
KGS 86.79971
KHR 4034.842477
KMF 469.450303
KPW 899.999621
KRW 1439.139417
KWD 0.307301
KYD 0.83388
KZT 523.502506
LAK 21958.919741
LBP 89607.455306
LKR 290.752962
LRD 179.119238
LSL 18.088971
LTL 2.95274
LVL 0.60489
LYD 4.883337
MAD 10.000285
MDL 18.31227
MGA 4702.358311
MKD 58.437734
MMK 3247.960992
MNT 3397.999946
MOP 8.022708
MRU 39.634645
MUR 46.750214
MVR 15.449895
MWK 1735.181963
MXN 20.340735
MYR 4.47018
MZN 63.926387
NAD 18.088799
NGN 1655.739736
NIO 36.820784
NOK 11.070865
NPR 135.561388
NZD 1.701056
OMR 0.385011
PAB 1.000666
PEN 3.747979
PGK 4.039636
PHP 58.607016
PKR 278.033626
PLN 4.08634
PYG 7796.764899
QAR 3.648614
RON 4.737023
RSD 111.311037
RUB 106.869445
RWF 1380.861362
SAR 3.75705
SBD 8.334636
SCR 13.630437
SDG 601.497594
SEK 11.01846
SGD 1.346196
SHP 0.789317
SLE 22.794655
SLL 20969.504736
SOS 571.895891
SRD 35.381502
STD 20697.981008
SVC 8.755771
SYP 2512.529858
SZL 18.094505
THB 34.432003
TJS 10.906999
TMT 3.51
TND 3.153415
TOP 2.3421
TRY 34.747825
TTD 6.771586
TWD 32.639498
TZS 2635.000338
UAH 41.781449
UGX 3682.008368
UYU 43.20248
UZS 12834.265282
VES 47.668239
VND 25405
VUV 118.722009
WST 2.791591
XAF 623.776377
XAG 0.03253
XAU 0.000379
XCD 2.70255
XDR 0.761133
XOF 623.776377
XPF 113.409218
YER 250.39143
ZAR 18.146825
ZMK 9001.149256
ZMW 27.042602
ZWL 321.999592
  • RIO

    0.5700

    63.84

    +0.89%

  • SCS

    -0.1200

    13.6

    -0.88%

  • BCC

    -1.0300

    146.49

    -0.7%

  • CMSC

    -0.0100

    24.56

    -0.04%

  • BCE

    0.0900

    27.13

    +0.33%

  • CMSD

    -0.0800

    24.31

    -0.33%

  • JRI

    0.0100

    13.51

    +0.07%

  • NGG

    -0.2400

    63.14

    -0.38%

  • RBGPF

    -1.6900

    60.31

    -2.8%

  • GSK

    0.6990

    35.009

    +2%

  • BP

    0.5050

    29.495

    +1.71%

  • RELX

    0.2100

    47.54

    +0.44%

  • BTI

    -0.4090

    37.321

    -1.1%

  • RYCEF

    0.2000

    7.44

    +2.69%

  • AZN

    1.2500

    68.29

    +1.83%

  • VOD

    0.0050

    8.875

    +0.06%

Who should get paid for nature's sequenced genes?
Who should get paid for nature's sequenced genes? / Photo: © AFP/File

Who should get paid for nature's sequenced genes?

Much of the vanilla that flavors our ice cream today is artificial, derived from the genetic signature of a plant that hundreds of years ago was known only to an Indigenous Mexican tribe.

Text size:

The plant's sequenced genomic information, available on public databases, was used as the basis for a synthetic flavoring that today competes with vanilla grown in several countries, mainly by small-scale farmers.

Few, if any, benefits of the lucrative scientific advance have trickled down to the communities that gave us vanilla in the first place.

"Wild genetic resources and pharmaceuticals ... are a multi-multi-billion dollar businesses. They clearly are profitable... that's not in dispute," Charles Barber of the World Resources Institute think tank told AFP.

"A great deal of really valuable information has fed into the system from research and utilization of wild genetic resources. And there is no mechanism currently to compensate the people where this information is coming from" in the form of digitally sequenced data, he added.

Much of the information comes from poor countries.

Fair sharing of the gains derived from digitally-stored genetic sequencing data has been a headache for negotiators at the COP16 biodiversity summit into its second week in Cali, Colombia.

At the last conference, in Montreal in 2022, 196 country parties to the UN's Convention on Biological Diversity (CBD) agreed to create a benefit-sharing mechanism for the use of digital sequence information (DSI).

Two years later, they still need to resolve such basic questions as who pays, how much, into which fund, and to whom does the money go?

- 'Cheap and very fast' -

The issue is a complex one.

There is little debate that genetic data-sharing on mostly free-access platforms is crucial for human advancement through medicine and vaccine development, for example.

But how to quantify the value of the sequenced information itself? And should the first people to discover a plant's particular usefulness be compensated?

"Sequencing technology has become so advanced that you can go with a... handheld device a little bit bigger than a cell phone and you can literally sequence a genome in an hour or two and upload it as you sequence it," Pierre du Plessis, a DSI expert and former negotiator for African countries at the CBD told AFP.

These gene sequences are then uploaded to databases which artificial intelligence can mine for potential leads for product development.

DSI is worth an estimated hundreds of billions of dollars a year. And there is a lot of it out there.

"Once the sequence is put into a public database, generally, no benefit-sharing obligations apply," Nithin Ramakrishnan, a researcher with the Third World Network, an advocacy NGO for developing countries, told AFP in Cali.

"Like when the sandalwood sequence information is available in the database whether India wants to share its sandalwood... with a cosmetic company or not, doesn't matter.

- Mandatory -

A point of contention in Cali is a demand from developing countries that payment for DSI use be mandatory, perhaps through a one-percent levy on profits from drugs, cosmetics or other products.

They also want guarantees of non-monetary benefits such as access to vaccines produced from genetic information sequenced from viruses and other pathogens.

"We want real understanding, sector-specific understanding of what non-monetary benefits will be shared and we want the system to be obligatory -- the users should have some form of obligation to share benefits," said Ramakrishnan.

Another sticking point is access for Indigenous people and local communities to DSI funds.

Developing countries want the information on genetic databases to be traceable and "answerable to governments" of the countries where it comes from, said Ramakrishnan.

But rich nations and many researchers oppose such a model which they fear will be too onerous, potentially putting the brakes on scientific pursuits that could benefit all humankind.

With such divergent points of view, observers are doubtful the Cali COP will emerge with any firm decisions on the outstanding questions by closing time on Friday.

The World Wildlife Fund has said "many more rounds of negotiations appear necessary" on DSI.

Added Barber: "I think it's not going to all get solved here."

T.Harrison--TFWP